Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Taiwan Liposome sales and marketing update

Taiwan Liposome launched AmBiL amphotericin B - a generic version of antifungal drug

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE